About Align Technology Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.aligntech.com/
Frequently Asked Questions
What is the 52-week range for ALGN?
The 52-week high is $200.44 and the 52-week low is $124.91.
What is the P/E ratio for ALGN?
The Price to Earnings (P/E) ratio is 24.89.
What is the dividend yield for ALGN?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 10.09%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 9.99%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 2.77.
Analyst Recommendation Trends
Wall Street analyst consensus for ALGN over the last few months:
Latest ALGN News
Is Align Technology (ALGN) Undervalued As Its October 28 Earnings Date Nears?
Align Technology (ALGN) has put a date on its next checkpoint. The company plans to release third quarter 2026 results on 28 October after the close, with a webcast discussing the figures shortly after. Align Technology enters this earnings date with the share price at about US$145.35, after a slide of around 6% over the past month and roughly 21% over the last quarter. The 1 year total shareholder return of about 12.9% contrasts with a much weaker 3 and 5 year record, suggesting shorter term...
Will Align Technology (ALGN) Beat Estimates Again in Its Next Earnings Report?
Align Technology (ALGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Align Technology (ALGN) Is Featured As A Key Dental Equipment Player
Align Technology (NasdaqGS:ALGN) has been highlighted as a key participant in new reports on the global dental equipment market. Researchers cite emerging demand for digital dentistry tools and cosmetic treatments as major drivers in these market assessments. The reports position Align Technology alongside other dental equipment suppliers as exposure to these themes attracts fresh investor attention. Align being profiled as a major player in dental equipment growth is useful context, but not...
Align Technology to Announce Third Quarter 2026 Results on October 28, 2026
TEMPE, Ariz., October 01, 2026--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2026 financial results on Wednesday, October 28, 2026, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and
New Senior Commercial Appointments at Neuromod
Neuromod Devices has announced the appointment of Joe Ghiz as Chief Commercial Officer (CCO) and Shannon Basham as VP of Channel Development.
3 Cash-Producing Stocks That Fall Short
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Dental Equipment Market Forecasts Growth from $8.31B (2026) to $11.48B by 2031, Profiling Envista, Carestream Dental, Nakanishi & Dentsply Sirona
The global dental equipment market is projected to grow from USD 8.31 billion in 2026 to USD 11.48 billion by 2031, registering a 5.5% CAGR. Growth is driven by rising oral health disorders, demand for cosmetic and preventive dentistry, dental tourism, and adoption of digital imaging, CAD/CAM, intraoral scanners, laser dentistry, and 3D printing. Therapeutic dental equipment will hold the largest market share, while hospitals and clinics remain the leading end users. The US is expected to record
Align Technology Launches "SHIFT Happens" U.S. Campaign to Educate Adults About Lifelong Tooth Movement
TEMPE, Ariz., September 28, 2026--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the launch of SHIFT Happens, a new consumer campaign designed to help Invisalign-trained doctors connect with and educate adult consumers about lifelong tooth movement and explain the
Align Technology (NASDAQ:ALGN): An Undervalued Value Stock Backed by Strong Profits and No Debt
ALGN looks undervalued with strong profitability, no debt, and moderate growth, making Align Technology a potential value stock to watch.
1 of Wall Street’s Favorite Stocks Worth Your Attention and 2 We Question
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Here's What Might Affect CVS Health's 2026 Financial Outlook
CVS raises its 2026 revenue and earnings outlook, but reimbursement pressure, macro headwinds and soft front-store demand could weigh on results.
Align Technology Stock: Is ALGN Underperforming the Healthcare Sector?
Align Technology has lagged the broader market over the past year, even as Wall Street analysts remain cautiously optimistic about the company’s future prospects.
Align Technology Sees Invisalign Growth Runway Despite Consumer Headwinds
Align Technology (NASDAQ:ALGN) sees continued growth potential for Invisalign clear aligners in the United States and internationally despite a challenging consumer environment, Chief Financial Officer John Morici said during a Baird investor conference. Morici said inflation and patient reluctance
Align Technology, Inc. (ALGN) Presents at 2026 Global Healthcare Conference Transcript
Align Technology, Inc. (ALGN) 2026 Global Healthcare Conference September 15, 2026 3:10 PM EDTCompany ParticipantsJohn Morici - CFO & Executive VP of...
1 S&P 500 Stock Worth Your Attention and 2 We Avoid
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Should You Continue to Hold ALGN Stock in Your Portfolio?
Align Technology expands Invisalign and digital dentistry adoption as iTero gains traction, but weak capital spending and currency volatility remain risks.
3 Value Stocks Walking a Fine Line
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Align Technology to Speak at Upcoming Financial Conference
TEMPE, Ariz., September 08, 2026--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at the following financial conference. The presentation will be webcast live via the Investor Relations section of Align's website at
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.
Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?
Technology is becoming a bigger part of CAH's strategy, linking distribution, specialty services and logistics through digital workflows.
Here's How CVS Is Focusing on Aetna's Profitability Turnaround
CVS Health is advancing Aetna's profitability turnaround, supported by stronger Health Care Benefits results, an improved MBR and operational initiatives.
Has Align Technology (ALGN) Fallen Far Enough To Look Undervalued?
Align Technology stock has delivered a steeply negative 5 year share price performance, yet current valuation checks suggest the market price may now be below what its cash flows imply. At the same time, traditional market multiples look roughly in line with peers, which leaves investors weighing an intrinsic value signal that points to a discount against a share price that does not screen as extreme on earnings based measures. Over the past 5 years, Align Technology shares have declined...
What Does Align Technology (ALGN) Gain From Its Board Change?
Align Technology (NasdaqGS:ALGN) appoints Quentin Blackford of iRhythm Technologies to its board of directors. Andrea L. Saia plans to resign from Align Technology's board after serving for more than a decade. The board change introduces new operating and strategy experience as Align Technology marks the end of Saia's long tenure during its growth as a digital dentistry leader. For investors tracking how leadership shifts can influence long term direction, it can be useful to compare Align...
Align Technology (ALGN) Could Be 24% Undervalued On Mixed Earnings Guidance
Align Technology (ALGN) is back in focus after its latest earnings report, which met revenue expectations and exceeded earnings forecasts, while also including softer guidance amid pricing and economic pressures across the sector. Align Technology’s recent guidance weighed on sentiment, and the stock has fallen about 12% since the earnings release. This contributed to a 9.26% decline in the 30 day share price return, even though the 1 year total shareholder return of 14.03% remains positive...
2 of Wall Street’s Favorite Stocks with Exciting Potential and 1 We Find Risky
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Q2 Earnings Outperformers: Align Technology (NASDAQ:ALGN) And The Rest Of The Dental Equipment & Technology Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Align Technology (NASDAQ:ALGN) and its peers.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-27 | Blackford Quentin S. | +1,376 | - | - |
| 2026-05-20 | Vitalone Britt J. | +1,836 | - | - |
| 2026-05-20 | Vitalone Britt J. | -1,443 | - | - |
| 2026-05-20 | Vitalone Britt J. | +1,443 | - | - |
| 2026-05-20 | SIEGEL SUSAN E | +1,836 | - | - |
| 2026-05-20 | SIEGEL SUSAN E | -1,745 | - | - |
| 2026-05-20 | SIEGEL SUSAN E | +1,745 | - | - |
| 2026-05-20 | Saia Andrea Lynn | +1,836 | - | - |
| 2026-05-20 | Saia Andrea Lynn | -1,745 | - | - |
| 2026-05-20 | Saia Andrea Lynn | +1,745 | - | - |
| 2026-05-20 | Poul Mojdeh | +1,836 | - | - |
| 2026-05-20 | Poul Mojdeh | -1,745 | - | - |
| 2026-05-20 | Poul Mojdeh | +1,745 | - | - |
| 2026-05-20 | Myong Anne | +1,836 | - | - |
| 2026-05-20 | Myong Anne | -1,745 | - | - |
| 2026-05-20 | Myong Anne | +1,745 | - | - |
| 2026-05-20 | Dallas Kevin J | +1,836 | - | - |
| 2026-05-20 | Dallas Kevin J | -1,745 | - | - |
| 2026-05-20 | Dallas Kevin J | +1,745 | - | - |
| 2026-05-20 | LACOB JOSEPH | +1,836 | - | - |
| 2026-05-20 | LACOB JOSEPH | -1,745 | - | - |
| 2026-05-20 | LACOB JOSEPH | +1,745 | - | - |
| 2026-05-20 | Conroy Kevin T | +1,836 | - | - |
| 2026-05-20 | Conroy Kevin T | -1,745 | - | - |
| 2026-05-20 | Conroy Kevin T | +1,745 | - | - |
| 2026-05-20 | MORROW GEORGE J | -1,745 | - | - |
| 2026-05-20 | MORROW GEORGE J | +1,745 | - | - |
| 2026-05-20 | LARKIN C RAYMOND JR | +2,448 | - | - |
| 2026-05-20 | LARKIN C RAYMOND JR | -2,326 | - | - |
| 2026-05-20 | LARKIN C RAYMOND JR | +2,326 | - | - |
| 2026-02-20 | Morici John | -718 | - | - |
| 2026-02-20 | Morici John | -4,653 | - | - |
| 2026-02-20 | Morici John | -389 | - | - |
| 2026-02-20 | Morici John | -1,251 | - | - |
| 2026-02-20 | Morici John | -837 | - | - |
| 2026-02-20 | Morici John | +17,102 | - | - |
| 2026-02-20 | Morici John | +8,423 | - | - |
| 2026-02-20 | Morici John | -2,549 | $190.02 | $484,361 |
| 2026-02-20 | Morici John | +7,848 | - | - |
| 2026-02-20 | Hockridge Stuart A | -419 | - | - |
| 2026-02-20 | Hockridge Stuart A | -2,714 | - | - |
| 2026-02-20 | Hockridge Stuart A | -227 | - | - |
| 2026-02-20 | Hockridge Stuart A | -531 | - | - |
| 2026-02-20 | Hockridge Stuart A | -419 | - | - |
| 2026-02-20 | Hockridge Stuart A | -1,210 | $190.02 | $229,924 |
| 2026-02-20 | Hockridge Stuart A | +4,310 | - | - |
| 2026-02-20 | Coletti Julie Ann | -538 | - | - |
| 2026-02-20 | Coletti Julie Ann | -3,490 | - | - |
| 2026-02-20 | Coletti Julie Ann | -291 | - | - |
| 2026-02-20 | Coletti Julie Ann | -947 | - | - |
| 2026-02-20 | Coletti Julie Ann | -598 | - | - |
| 2026-02-20 | Coletti Julie Ann | +11,153 | - | - |
| 2026-02-20 | Coletti Julie Ann | +5,493 | - | - |
| 2026-02-20 | Coletti Julie Ann | -1,718 | $190.02 | $326,454 |
| 2026-02-20 | Coletti Julie Ann | +5,864 | - | - |
| 2026-02-20 | HOGAN JOSEPH M | -3,397 | - | - |
| 2026-02-20 | HOGAN JOSEPH M | -3,672 | - | - |
| 2026-02-20 | HOGAN JOSEPH M | -27,353 | - | - |
| 2026-02-20 | HOGAN JOSEPH M | -1,865 | - | - |
| 2026-02-20 | HOGAN JOSEPH M | -3,961 | - | - |
| 2026-02-20 | HOGAN JOSEPH M | +44,670 | - | - |
| 2026-02-20 | HOGAN JOSEPH M | +19,144 | - | - |
| 2026-02-20 | HOGAN JOSEPH M | -16,107 | $190.02 | $3,060,652 |
| 2026-02-20 | HOGAN JOSEPH M | +40,248 | - | - |
| 2026-02-18 | Morici John | -7,969 | $189.3143 | $1,508,646 |